The Next Phase Of COVID-19: Hope & Hesitancy Towards A Vaccine
Though 2020 has been filled to the brim with challenges, we're starting to see a wave of optimism as we inch closer to the new year: With pharmaceutical companies and vaccine candidates Pfizer-BioNTech and Moderna nearing federal clearance (AstraZeneca, also promising, is still in Phase 3 trials), there's a sliver of hope for an end to the COVID-19 pandemic. With that optimism, though, many more challenges remain ahead. The 21 million health care workers and 3 million living in elderly care homes will be first in line to receive the vaccine, no doubt, but who comes after? Will certain employe...